Biotech Values

[dewophile]

PFE could be candidate if they divested their PD-L1 program co-owned by Merck KGaA

I bet they wouldn't need to divest this program. There are plenty of PD-1/PD-L1s out there, and some companies are pursuing both PD-1 and PD-L1

PS: I thought PFE should buy BMY instead of wyeth back in the day if you recall (I owned alot of BMY back then)
PPS: I think BMY is a good value here as well